1. Home
  2. PSTV vs HUBC Comparison

PSTV vs HUBC Comparison

Compare PSTV & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • HUBC
  • Stock Information
  • Founded
  • PSTV 1996
  • HUBC 2017
  • Country
  • PSTV United States
  • HUBC Israel
  • Employees
  • PSTV 20
  • HUBC N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • HUBC
  • Sector
  • PSTV Health Care
  • HUBC
  • Exchange
  • PSTV Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • PSTV 10.4M
  • HUBC 7.6M
  • IPO Year
  • PSTV N/A
  • HUBC N/A
  • Fundamental
  • Price
  • PSTV $1.82
  • HUBC $0.72
  • Analyst Decision
  • PSTV Strong Buy
  • HUBC
  • Analyst Count
  • PSTV 1
  • HUBC 0
  • Target Price
  • PSTV $8.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • PSTV 41.1K
  • HUBC 557.0K
  • Earning Date
  • PSTV 08-12-2024
  • HUBC 08-23-2024
  • Dividend Yield
  • PSTV N/A
  • HUBC N/A
  • EPS Growth
  • PSTV N/A
  • HUBC N/A
  • EPS
  • PSTV N/A
  • HUBC N/A
  • Revenue
  • PSTV $6,084,000.00
  • HUBC $73,037,000.00
  • Revenue This Year
  • PSTV $5.21
  • HUBC N/A
  • Revenue Next Year
  • PSTV N/A
  • HUBC N/A
  • P/E Ratio
  • PSTV N/A
  • HUBC N/A
  • Revenue Growth
  • PSTV 733.42
  • HUBC 124.59
  • 52 Week Low
  • PSTV $0.97
  • HUBC $0.66
  • 52 Week High
  • PSTV $3.21
  • HUBC $9.40
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 51.37
  • HUBC 41.18
  • Support Level
  • PSTV $1.40
  • HUBC $0.66
  • Resistance Level
  • PSTV $1.59
  • HUBC $0.82
  • Average True Range (ATR)
  • PSTV 0.16
  • HUBC 0.07
  • MACD
  • PSTV 0.04
  • HUBC -0.01
  • Stochastic Oscillator
  • PSTV 78.15
  • HUBC 17.70

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software and quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services.

Share on Social Networks: